🆕 just when you thought triple #antithrombotic therapy was✌🏼…in comes #rivaroxaban 2.5mg BID x 30d ➕#DAPT in anterior wall #STEMI to PREVENT, not treat #LVT🫀 ▫️age <75 ▫️CrCl ~ 90 ▫️60% ticagrelor ▫️ LVT 1,0.7% riva 🆚 12,8.6% in DAPT⤵️ JACC Journals jacc.org/doi/10.1016/j.…

Check out one of our ⭐️ PGY1 residents, Olivia Nuti for receiving an award for Outstanding Platform Presentation during the Residency Research & Practice Forum!! 🥳👏🎉Congrats to her and all of our presenting residents for their hardwork!! 🙂🙂#NYSCHPAA2022 #PharmRes #TwitteRx

FDA-Sponsored study of levothyroxine generic interchangeability. In >15k patients tx w/ levothyroxine, those who 🔁 among #generic 💊 maintained the same level of thyroid function (📏as indicated by avg blood thyrotropin level) vs pts using a single #levothyroxine product.

The Use of High-Dose Corticosteroids Versus Low-Dose Corticosteroids With and Without Tocilizumab in COVID-19 Acute Respiratory Distress Syndrome - Alyson journals.sagepub.com/doi/full/10.11… 2/3

Congratulations to our pgy2 class! We are all very proud of all your achievements!!!

Big congrats to our wonderful PGY-1 class of 2021-2022 for the completion of their residency year! We're all so proud of your accomplishments and are excited to see the amazing things you'll do during your PGY-2 years!💊🎓👏🥳🎉 #PharmRes #Graduation #TwitteRx

Also celebrating the graduation of our stellar PGY-2 class of 2021-2022 for completing their residency training! We are all excited to watch you begin your careers as brand new clinical pharmacotherapy specialists! 👨‍🎓🥼💊 #PharmRes #PGYDone

Vanc-pip/tazo and AKI: a sheep in wolf’s clothing? For many, the notion that vanc+pip/tazo is nephrotoxic has become accepted dogma. In our new study in Intensive Care Medicine, we try to turn that idea on its head link.springer.com/article/10.100… 1/n

Dr. David Fridman, Diana Altshuler பிரித்திவ் Scott Weisenberg Sarah Hochman Polina Trachuk, MD are among authors who describe outcomes of cytomegalovirus viremia treatment in critically-ill patients with #covid19 infection in Open Forum Infectious Diseases 🔓 bit.ly/3CTynTs

Excited to be here! #SCCM2023 Jerry Altshuler

Hands down the best plenary session! What a powerful story!!! Excited to have met Dr. Glaucomflecken Lady Glaucomflecken (she/her) #SCCM2023

Congratulations to the 2023 ACCM Fellows and Masters! #SCCM2023

Diana Altshuler